Comments

HLS Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does HLS Therapeutics (HLTRF) operate in?

HLS Therapeutics is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the OTCPK.

HLTRFOTCPK

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

HLS Therapeutics (HLTRF) Forecast

News Earnings HLS Therapeutics (HLTRF) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

HLS Therapeutics Stock Price, Quotes and Forecasts | OTC:HLTRF | Benzinga

Explore HLS Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for HLTRF.

Open	-
Close	-
Volume / Avg.	0 / 961.00
Day Range	- - -
52 Wk Range	2.22 - 3.44
Market Cap	$101.86M
P/E Ratio	-
Dividend Yield	-
Exchange	OTC
RSI	0
Short Interest	-
Days to Cover	1

Recent News

No news found

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Open	-
Close	-
Volume / Avg.	0 / 961.00
Day Range	- - -
52 Wk Range	2.22 - 3.44
Market Cap	$101.86M
P/E Ratio	-
Dividend Yield	-
Exchange	OTC
RSI	0
Short Interest	-
Days to Cover	1

About

Sector

Healthcare

Industry

N/A

HLS Therapeutics Inc is a specialty pharmaceutical company. It is focused on the acquisition and com...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy HLS Therapeutics (HLTRF) stock?

You can purchase shares of HLS Therapeutics (OTCPK:HLTRF) through any online brokerage.

View our list of the best stock brokerages

Who are HLS Therapeutics (HLTRF) competitors?

There are no as such competitors for HLS Therapeutics.

What is the forecast, or price target, for HLS Therapeutics (HLTRF) stock?

HLS Therapeutics has a consensus price target of $5.00.

What is the current price for HLS Therapeutics (HLTRF)?

The stock price for HLS Therapeutics (OTCPK: HLTRF) is $ last updated December 31, 1969 at 7:00 PM EST.

Does HLS Therapeutics (HLTRF) pay a dividend?

A quarterly cash dividend of 0.04 per share of Class A Common Stock. The quarterly cash dividend was payable on December 14, 2018 to stockholders of record on October 23, 2018.

When is HLS Therapeutics (OTCPK:HLTRF) reporting earnings?

HLS Therapeutics does not have any upcoming earnings scheduled.

Is HLS Therapeutics (HLTRF) going to split?

There is no upcoming split for HLS Therapeutics.

What sector and industry does HLS Therapeutics (HLTRF) operate in?

HLS Therapeutics is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the OTCPK.